Companies suggested by investor Carl Icahn as potential buyers for Clorox are unlikely to make offers higher than Ichan's $78-per-share bid, experts say. The reason is that Icahn's bid values Clorox at a price-to-earnings ratio that is higher than industry leaders such as Procter & Gamble, Colgate-Palmolive and Unilever. "I don't see too many buyers coming out of the woodwork for such an expensive stock," said Jack Ablin, chief investment officer for Harris Private Bank.

Full Story:

Related Summaries